Ongoing selection for a uniquely human null allele of SIGLEC12 in world‐wide populations may protect against the risk of advanced carcinomas

• Shoib S. Siddiqui,
• Michael Vaill,
• Ajit Varki

Affiliations

Shoib S. Siddiqui

Departments of Medicine and Cellular and Molecular Medicine Glycobiology Research and Training Center, and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA

Michael Vaill

Departments of Medicine and Cellular and Molecular Medicine Glycobiology Research and Training Center, and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA

Ajit Varki

Departments of Medicine and Cellular and Molecular Medicine Glycobiology Research and Training Center, and Center for Academic Research and Training in Anthropogeny University of California San Diego CA USA